SCHEMBL8624732

SCHEMBL8624732

CC(N)C(Cc1ccc(F)c(-c2ccccc2)c1)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 6/20 0.41
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CNR1 P21554 5/20 0.38
CNR2 P34972 3/20 0.38
MDM2 Q00987 1/20 0.38
BACE1 P56817 2/20 0.37
PTGS1 P23219 3/20 0.36
MEN1 O00255 2/20 0.36
PTGS2 P35354 2/20 0.36
KMT2A Q03164 2/20 0.36
FABP2 P12104 1/20 0.36
TSHR P16473 1/20 0.36
AKR1C4 P17516 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2C P28335 1/20 0.36
DRD3 P35462 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8621728 0.91 FDFT1 (0.47) FDFT1CNR1CNR2BACE1PTGS1
SCHEMBL8619570 0.86 APEX1 (0.43) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8625643 0.83 FDFT1 (0.53) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8620804 0.83 FDFT1 (0.53) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8625176 0.83 SLC6A3 (0.46) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8623834 0.83 FDFT1 (0.53) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8623070 0.83 FDFT1 (0.53) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8623149 0.82 PNMT (0.46) FDFT1SLC6A2SLC6A3CNR1CNR2
Hydrochloric Acid SCHEMBL7761818 0.81 FDFT1 (0.52) FDFT1SLC6A2SLC6A3CNR1CNR2
SCHEMBL8625042 0.80 FDFT1 (0.62) FDFT1BACE1PTGS1MEN1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5777150-A Substituted amic acid derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-07-07 US disclosed
EP-0611749-B1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMA CO LTD (JP) 1997-10-22 EP disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed